NEU:ASX
Neuren Pharmaceuticals Ltd
A$20.29
arrow_downward
-0.69%(-0.14) 1D
Oct 6, 11:01:58 AM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEU...
Open
A$20.48
High
A$20.54
Low
A$20.13
Mkt. cap
2.57B
Avg. vol.
443.25K
Volume
30.49K
Dividend
0.74%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
131.44
52-wk high
A$23.76
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
Open
A$20.48
High
A$20.54
Low
A$20.13
Mkt. cap
2.57B
Avg. vol.
443.25K
Volume
30.49K
Dividend
0.74%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
131.44
52-wk high
A$23.76
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
News stories
From web sources and news partners
Simply Wall Street
·
45 minutes ago
Is Monster Beverage (MNST) Cheap After Its Americas Leadership Shake Up?
24/7 Wall St.
·
1 hour ago
Forget JEPQ: Goldman's Nasdaq Income Fund Raised Its October Payout While JPMorgan Cut Its Own
Moomoo
·
52 minutes ago
U.S. Treasury Sell-Off Fails to Halt Stock Rally; Three Major Indices Close Higher as Nasdaq Hits Record High
Yahoo Finance
·
1 hour ago
Goldman Sachs spills the beans on what’s next for S&P 500
About Neuren Pharmaceuticals Ltd
CEOJon Pilcher
Employees8
Founded2001
Headquarters-
SectorPharmaceutical industry
Websiteneurenpharma.com